Smith Group Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$726K	Buy	21,951 +1,865	+9%	+$79K	0.04%	109
2025 Q4	$930K	Buy	20,086 +498	+3%	+$20.8K	0.05%	101
2025 Q3	$685K	Buy	19,588 +576	+3%	+$20K	0.04%	114
2025 Q2	$562K	Sell	19,012 -73	-0.4%	-$2.08K	0.04%	122
2025 Q1	$570K	Buy	19,085 +73	+0.4%	+$2.23K	0.04%	123
2024 Q4	$545K	Buy	19,012 +188	+1%	+$6.22K	0.04%	136
2024 Q3	$727K	Buy	18,824 +3,774	+25%	+$135K	0.06%	76
2024 Q2	$485K	Buy	15,050 +90	+0.6%	+$3.12K	0.04%	84
2024 Q1	$581K	Hold	14,960	–	–	0.03%	129
2023 Q4	$460K	Buy	+14,960	New	+$375K	0.03%	133
2022 Q1	$241K	Sell	11,815 -8,487	-42%	-$160K	0.01%	157
2021 Q4	$379K	Sell	20,302 -524	-3%	-$10.2K	0.02%	153
2021 Q3	$411K	Sell	20,826 -334	-2%	-$7.22K	0.02%	144
2021 Q2	$500K	Sell	21,160 -205	-1%	-$4.74K	0.02%	135
2021 Q1	$506K	Hold	21,365	–	–	0.03%	131
2020 Q4	$428K	Sell	21,365 -6,970	-25%	-$136K	0.02%	145
2020 Q3	$590K	Sell	28,335 -3,420	-11%	-$61.7K	0.03%	121
2020 Q2	$556K	Sell	31,755 -19,758	-38%	-$387K	0.03%	127
2020 Q1	$841K	Buy	51,513 +35,883	+230%	+$741K	0.05%	98
2019 Q4	$322K	Hold	15,630	–	–	0.01%	164
2019 Q3	$179K	Buy	+15,630	New	+$178K	0.01%	198